17/10/2023 - Innovation, Projects, Research, Success Stories

Two projects from IGTP funded by ”la Caixa” Foundation to transition their innovative research from the laboratory to patients

The first urine test that detects kidney fibrosis as an alternative to kidney biopsies, an initiative from the IVECAT group, and a project applying artificial intelligence to rapidly categorise stroke patients and enhance their recovery chances, from the Neurovascular Research group, are two of the fifteen projects from Catalan research centres selected within the 2023 call of the new CaixaImpulse Healthcare Innovation programme.

02/10/2023 - Campus Can Ruti, Projects, Research

Self-sampling proves effective in diagnosing asymptomatic mpox

An article published in Nature Communications on the pilot study carried out in Catalonia to evaluate the self-collection of biological samples reveals the high acceptability of the proposal and the key role of diagnosis in people without symptoms of mpox.

28/09/2023 - Campus Can Ruti, Research

Reviving a depleted immune system: an unmet goal for people on HIV treatment

A study has identified a molecule that could potentially be a target for the development of immunotherapies, led by IrsiCaixa AIDS Research Institute and spearheaded by Julia García-Prado, principal investigator at the same centre and scientific director of the Germans Trias i Pujol Research Institute (IGTP).

22/09/2023 - Projects, Research

InMaM project: innovative immunotherapies to treat breast cancer

The collaborative project InMaM, part of the Complementary Plan for Biotechnology Applied to Health, involving both Catalonia and the Basque Country, aims to discover new immunotherapy-based treatments for metastatic breast cancer.

13/09/2023 - Projects, Research

Taking patients with haemorrhagic stroke to the nearest centre improves their prognosis

A study co-led by researchers from IGTP, IIB Sant Pau and IDIBGI concludes that direct transport to a referral centre for endovascular treatment may not be the best option for patients with a final diagnosis of intracerebral haemorrhage or haemorrhagic stroke.

07/09/2023 - Research

New research identifies 28 genetic regions linked to susceptibility and severity of COVID-19

A study published in Nature unveils new genetic insights into COVID-19 susceptibility and severity. This work marks a significant advancement in our understanding of the role genetics play in determining COVID-19 outcomes.

05/09/2023 - Conferences, Projects, Research, Success Stories

RIGHT PLUS network formalised in Buenos Aires as a collaboration between academic centres and civil society in Ibero-America

The Ibero-American network RIGHT PLUS, of which the CEEISCAT is a founding member and, together with Coalition Plus, co-coordinator, has presented its launch at a meeting in Buenos Aires (Argentina) on 28-29 August.

02/08/2023 - Research

The CEEISCAT collaborates with UNAIDS and the Ministry of Public Health of the Dominican Republic to improve retention in antiretroviral treatments for HIV

Dr Jordi Casabona spent a week on the island working directly with international organizations, ministries, hospitals, and civil society.

29/06/2023 - Campus Can Ruti, Research

New lung cancer treatment boosts survival and could benefit more than 6,000 patients a year

A new lung cancer treatment has allowed 36.8% of patients to achieve complete tumour disappearance, compared to the 6.9% rate of the standard post-surgery treatment. In addition, 85% of patients survive two years after receiving chemo-immunotherapy before surgery compared to 63% who receive chemotherapy alone before surgery. The study involved oncologist from ICO Badalona and IGTP researcher, Teresa Morán.

28/06/2023 - Campus Can Ruti, Research

TÉSTATE PrEP study underway

Recruitment for the clinical trial TÉSTATE PrEP has started. This clinical trial has been designed by the Centre for Epidemiological Studies on HIV/AIDS in Catalonia (CEEISCAT) to implement a pilot plan for online HIV/STI screening in PrEP users.